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Available online 5 June 2018Mesial temporal lobe epilepsy (mTLE) is the most common form of epilepsy, believed to arise in part from com-
promised GABAergic inhibition. The neuronal specific K+/Cl− co-transporter 2 (KCC2) is a critical determinant of
the efficacy of GABAergic inhibition anddeficits in its activity are observed inmTLEpatients and animalmodels of
epilepsy. To test if reductions of KCC2 activity directly contribute to the pathophysiology of mTLE, we locally ab-
lated KCC2 expression in a subset of principal neurons within the adult hippocampus. Deletion of KCC2 resulted
in compromised GABAergic inhibition and the development of spontaneous, recurrent generalized seizures.
Moreover, local ablation of KCC2 activity resulted in hippocampal sclerosis, a key pathological change seen in
mTLE. Collectively, our results demonstrate that local deficits in KCC2 activity within the hippocampus are suffi-
cient to precipitate mTLE.






Mesial temporal lobe epilepsy (mTLE) is the most common form of
human epilepsy, classified by unprovoked, spontaneous seizures origi-
natingwithin the temporal lobe.mTLE in humans develops over a latent
period of several years after a precipitating insult such as traumatic
brain injury, hypoxia, infection, or episodes of status epilepticus [1,2].
In addition to seizures, profound morphological changes are observed
in the brain, the most common being hippocampal sclerosis [3]. Scle-
rotic hippocampal tissue surgically removed fromhumanmTLE patients
shows widespread neuronal loss and gliosis [4]. Similar changes are
seen in convulsant-induced rodent models of mTLE [5].
While the cellular mechanisms that underlie the development
of mTLE remain poorly understood, deficits in the efficacy of γ-
aminobutyric acid (GABA) mediated inhibitory neurotransmission are
widely believed to be of significance [6–8]. Fast synaptic inhibitory
transmission in the brain is primarily mediated by chloride (Cl−)-
permeable γ-aminobutyric acid receptors (GABAARs), which upon
opening hyperpolarize the cell membrane through Cl− influx and
decrease neuronal firing. During development, the electroneutralnce, Tufts University School of
. This is an open access article underK+/Cl− co-transporter 2 (KCC2) becomes the dominant mediator of
Cl− extrusion, coupling Cl− efflux to the outwardly directed K+ gradi-
ent [9,10]. Deficits in KCC2-mediated Cl− extrusion result in increased
intracellular Cl− levels, permitting depolarizing GABAAR responses
[11]. KCC2 loss-of-function mutations in human patients result in se-
vere cases of epilepsy in infancy with migrating focal seizures [12,13].
In mice, a global loss of 95% of KCC2 results in seizures and mortality
at 2–3 weeks postnatal [14], and loss-of-function mutations increase
seizure susceptibility [15,16].
Reduced KCC2 levels and depolarizing GABAAR signaling are
observed in tissue surgically removed from mTLE patients [17–20]. In
rodent models of mTLE, reduced KCC2 is observed in the hippocampus
immediately after an initial precipitating injury and during subsequent
epileptogenesis [21–25]. However, it is unknown if these deficits di-
rectly contribute to the development of seizures and accompanying
pathophysiology of mTLE.
To test this, we have ablated KCC2 expression in a subset of principal
neurons in the hippocampus of adult mice. We show that reducing
KCC2 activity leads to increased neuronal Cl− accumulation and gross
deficits in GABAergic inhibition. Moreover, these deficits are sufficient
to initiate recurring generalized seizures, reactive astrogliosis, and neu-
ronal loss within the hippocampus, reproducing the core features of
mTLE with hippocampal sclerosis. Thus, local inhibition of KCC2 within
the hippocampus is sufficient to precipitate mTLE.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Animal Care
Animal studies were performed with protocols approved by the In-
stitutional Animal Care and Use Committee of Tufts Medical Center.
Mice were kept on a 12-h light/dark cycle with ad libitum access to
food and water.
2.2. Generation and Genotyping of KCC2FL Mice
KCC2FL mice (Slc12a5lox/lox) were have been described previous and
have been backcrossed on the C57BL/6 J mice for 10 generations [26].
PCR was with an expected product size of 426 bp for wild-type and
543 bp for KCC2FL mice.
2.3. Viral Injections
Adult (6–8 week old) male KCC2FL mice were stereotaxically
injected with adeno-associated virus (AAV) containing Cre
recombinase. Prior to surgery, mice were injected with buprenorphine
(0.75 mg/kg, s.c.) and anesthetized with isoflurane (1–3%). Drill holes
were made above each dorsal hippocampus (coordinates: AP -2.0 mm
from bregma, ML +/− 1.8 mm) and a Neuros syringe (Hamilton,
Reno, NV) lowered to 2.0mm below the brain surface. Mice were bilat-
erally injected with 0.5 μL of either AAV9·CaMKII·HI.eGFP-Cre.WPRE.
SV40 or AAV9·CaMKII0.4.eGFP·WPRE.rBG (titer: 1 × 1013 GC/mL in
PBS, University of Pennsylvania Vector Core, Philadelphia, PA) at a rate
of 50 nL/min. After injection, the needle remained in the brain 5 min be-
fore beingwithdrawn. The skinwas closed andmice placed on a heating
pad until mobile. Mice were singly housed post-surgery.
2.4. EEG/EMG and Video Recordings
A subset of virus-injectedmice were implanted with electroenceph-
alography/electromyography (EEG/EMG) headstages (2-channel,
Pinnacle Technology, Lawrence, KA) following virus injection. Implants
were aligned with lambda and 4 screws inserted for subdural recording
contacts above the right frontal and parietal lobes. The implant was
glued to the skull and mice recovered as above. After a recovery period
of 7 days, continuous paired video and EEG/EMG recordings were
collected using Sirenia Acquisition software (Pinnacle). Recordings
were processed using Sirenia Seizure (Pinnacle) and EEG seizure events
detected using DClamp (Massachusetts General Hospital Pediatric
Epilepsy Research Lab, Boston, MA). Seizure FFT spectra were created
using MATLAB (Mathworks, Natick, MA).
2.5. Slice Immunohistochemistry
Mouse brains were fixed by transcardial perfusion of PBS-buffered
4% paraformaldehyde (PFA) (Electron Microscopy Services, Hatfield,
PA) and removed to 4% PFA overnight, then cryoprotected in 30% su-
crose solution in PBS for 3 days before being frozen in optimal cutting
temperature medium (VWR, Radnor, PA). 40 μm serial coronal sections
were prepared using a Leica SM-2000Rmicrotome (Wetzlar, Germany).
Sections were kept at −20°C in cryoprotectant solution (876 mM su-
crose, 4 M polyvinylpyrrolidone, 30% ethylene glycol, and 10% PBS in
diH2O), and washed with PBS before blocking. Sections were blocked
with 10% normal goat serum (NGS) and 0.3% Triton X-100 in PBS for
2 h at room temperature. Sectionswere incubated overnightwith either
anti-KCC2 C-terminus (1:500 rabbit, Millipore 07–432, Darmstadt,
Germany), anti-GFAP (1:5000 mouse, Millipore MAB360), or anti-
NeuN (1:1000 mouse, Millipore MAB377). Slices were subsequently
labeled with Alexa-Fluor secondary antibodies (1:200; Thermo Fisher
Scientific, Waltham, MA) prior to mounting with ProLong Gold with
or without DAPI (Thermo Fisher). To measure KCC2 expression levelsZ-stack images were taken of the hippocampus at 20× using an Eclipse
Ti confocal microscope (Nikon, Tokyo, Japan). Regions of interest (ROI)
were drawn in the CA1 orDG and the average intensity for each ROIwas
normalized to themaximumaverage intensity per animal. Slices of each
animal were averaged and compared between groups at equivalent
time-points after virus injection. For NeuN, images were taken at 60×
of CA1 principal layer or dentate gyrus granule cell layer, and 100 μm2
ROIs drawn. NeuN positive labeled cells were counted in each ROI,
averaged for each animal and compared between groups. For GFAP la-
beling, images were obtained using a scanning fluorescencemicroscope
(BZ-X700, Keyence, Osaka, Japan) at 10x magnification. ROIs were
drawn around the CA1 or DG in each slice. A threshold was used create
a binarymask of GFAP labeling, and area calculated for ROI and reported
as amount of GFAP labeling/mm2. Values from each animal were aver-
aged and then compared between groups. All image processing was
performed using FIJI (ImageJ).
2.6. Slice Electrophysiology
Micewere anesthetized with isofluorane and brains removed. Coro-
nal slices (350 μm) were cut on a Leica VT1000s vibratome in ice-cold
cutting solution containing (in mM): 87 NaCl, 2.5 KCl, 0.5 CaCl2, 25
NaHCO3, 1.25 NaH2PO4, 7 MgCl2, 50 sucrose and 25 glucose, pH 7.4.
Slices were placed in a submerged chamber for a 1 h recovery period
at 32 °C in artificial cerebrospinal fluid (aCSF) containing (in mM):
126 NaCl, 26 NaHCO3, 2.5 KCl, 2 MgCl2, 2 CaCl2, 1 glutamine, 1.25
NaH2PO4, 1.5 Na-pyruvate and 10 glucose. All solutions were bubbled
with 95% O2/5% CO2. Gramicidin Perforated Patch Recordings. After a
1-h recovery, slices were placed in a submerged chamber (RC-27 L,
Warner Instruments, Hamden, CT). For perforated patch, micropipettes
(3–4 MΩ) contained saline (in mM): 140 KCl and 10 HEPES, pH 7.4
KOH, and were backfilled with gramicidin D (50 μg/mL, Sigma Aldrich)
to establish access resistances between 20 and 80 MΩ throughout the
recording period. Dentate gyrus granule cells were patched in the
outer 2/3 of the granule cell layer to avoid newborn granule cells. A
glass pipette (1–3 MΩ tip resistance) filled with muscimol (10 μM,
Tocris Bioscience, Bristol, UK) in aCSF was lowered into the molecular
layer of the dentate gyrus and pulses (500 ms) applied locally by
pressure ejection with a Picospritzer II (General Valve, Fairfield, NJ) to
activate GABAA-mediated currents in granule cells held at voltages
between −100 to −50 mV in 10-mV increments. EGABA values were
obtained from linear regression fits to the data at voltages near the ob-
servable reversal potential of Imuscimol. Tetrodotoxin (TTX, 400 nM,
Tocris) was applied to block activity-dependent shifts in EGABA and bu-
metanide (10 μM, Tocris) to inhibit NKCC1, and VU0463271 to inhibit
KCC2 (1 μM, AstraZeneca, Cambridge, UK). Voltages were corrected
offline with a liquid junction potential value of 3.8 mV. Recordings
were performed with a Multiclamp 700B amplifier and Clampex 10 ac-
quisition software. Data were low-pass filtered at 10 kHz and analyzed
offline with Clampfit (Molecular Devices, Sunnyvale, CA).
2.7. Primary Neuron Culture
Primary cortical/hippocampal neurons were prepared and cultured
as previously described [27]. Briefly, P0 KCC2FL mice were anesthetized
on ice and the brains removed. The brains were dissected in Hank's
buffered salt solution (HBSS, Invitrogen) with 10 mMHEPES. The corti-
ces and hippocampi were tripsinized and triturated to dissociate the
neurons. Cells were counted using a hemocytometer and plated on
poly-L-lysine-coated coverslips (for ICC and electrophysiology) or in
35mm dishes (for immunoblot) at a density of 1 × 105 or 4 × 105 cells
respectively. At days in vitro (DIV) 18, cells were exposed to control or
Cre AAV as described above at a concentration of 1 × 106 GC/mL. To
determine effect on neuronal viability, GFP-positive cells were counted
at DIV 24.
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Immunocytochemistry (ICC)was carried out as previously described
[28]. Briefly, primary cultured neurons were washed with PBS, fixed in
4% PFA in PBS, and permeabilized with 0.1% Triton X-100 in PBS. The
cells were then blocked in a solution containing 5% BSA and 5% goat
serum. Primary and secondary antibodies (as described above) were
prepared at a dilution of 1:1000 in block solution and incubated with
the cells for 1 h at room temperature in the dark. The cells were washed
in PBS and mounted using ProLong Gold.
2.9. Immunoblotting
Immunoblotting was carried out as previously described [29].
Briefly, proteins were isolated in RIPA lysis buffer (50 mM Tris, 150
mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate and 1% Triton X-100,
pH 7.4) and quantified using a Bradford assay (Bio-Rad, Hercules, CA,
USA). Samples were prepared in sample buffer and 20 μg of protein
was loaded onto a 7% (for KCC2) or 10% (for α-tubulin) polyacrylamide
gel. Proteinswere separated by sodiumdodecyl sulfate poly-acrylamide
gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose
membrane. Membranes were blocked in 5% milk in tris-buffered saline
1% Tween-20 (TBS-T) and incubatedwith primary antibodies anti-KCC2
C-terminus (1:1000 rabbit, Millipore 07-432), anti-KCC2 N-terminus
(1:1000 rabbit, LS-C135150, LifeSpan Biosciences, Seattle, WA) or
α-tubulin (1:5000 mouse, Sigma-Aldrich) for 1 h. The membranes
were washed and incubated for 1 h at room temperature with HRP-
conjugated secondary antibodies (1:5000 – Jackson ImmunoResearch
Laboratories, West Grove, PA, USA). Protein bands were visualized
with Pierce ECL (ThermoFisher) and imaged using a ChemiDoc MP
(Bio-Rad).
2.10. Culture Electrophysiology
Neurons were recorded at 33 °C in saline containing (in mM) 140
NaCl, 2.5 KCl, 2.5 MgCl2, 2.5 CaCl2, 10 HEPES, 11 glucose, pH 7.4 (NaOH).
All solutions were applied through a three-barrel microperfusion
apparatus (700 μm, Warner Instruments, Hampden, CT), and conductedFig. 1. Conditional inactivation of KCC2 in cultured neurons leads to elevated intracellular Cl− lev
mice showing discrimination betweenwild type, homozygous, or heterozygous for KCC2FL gene. U
transporter between residues Q911-Q1096. B. Neuronal cultures from KCC2FL mice were treated w
the lysates probedwith antibodies directed against N-terminal and C-terminal epitopes onKCC2. B
with increasing durations after infection. C. The efficacy of Cre-mediated knockout was confirme
currents (red trace) and membrane leak currents (black trace) were recorded during voltage ra
the traces and is aligned temporally. E. Exemplar leak-subtracted muscimol-activated currents fr
X-axis. F. Basal EGABA values were shifted to more positive levels in Cre-positive cultured neuronsin the presence of tetrodotoxin (300 nM) and bumetanide (10 μM) to
block voltage-dependent sodium channels and NKCC1, respectively.
Cells infected with control- or Cre-containing virus were selected by
epifluorescence for GFP expression. Data were acquired using Clampex
10 software at an acquisition rate of 10 kHz with an Axopatch 2B
amplifier and digitized with a Digidata 1440 (Molecular Devices).
To detect endogenous Cl− levels, cells were perforated with gramici-
din (50 mg/mL) dissolved in an internal pipette containing (in mM)
140 KCl, 10 HEPES, pH 7.4 (KOH) and a tip resistance of 3–4 MΩ. Fol-
lowing perforation to below a series resistance of 100MΩ, EGABA values
were found by application of muscimol (1 μM) during positive-going
voltage ramps (20 mV/s).
2.11. Statistical Analysis
Statistical analysis was performed with GraphPad 7 (San Diego, CA)
and R. Unpaired Student's t-tests were used unless otherwise indicated.
Data were expressed asmean± SEM, with significance set atα=0.05.
3. Results
3.1. Deletion of KCC2 in Cultured Hippocampal Neurons Increases Neuronal
Cl- Levels and Compromises GABAergic Inhibition
We have recently developed mice in which KCC2 expression can be
inactivated via Cre-recombinase mediated excision of exons 22-25 in
the respective gene SCN12A5. The deleted regions encodes the C-termi-
nal amino acids 911-1096 (KCC2FL Fig. 1A). These residues have been
established to play an essential role in transporter activity [30,31].
To assess the efficacy of this approach cultured neurons from the
KCC2FL mice were infected with adeno-associated viruses expressing
fluorescent GFP and Cre recombinase under the control of the CaMKIIα
promoter (AAV9-CaMKII-eGFP-Cre; AAV-Cre) to restrict expression of
the respective transgene to principal neurons [32]. 18-DIV hippocampal
cultures prepared from KCC2FL homozygotes were infected with AAV-
Cre or a similar virus construct containing GFP (AAV9-CaMKII-eGFP;
AAV-GFP) and 3–6 days later detergent solubilized lysates were sub-
jected to immunoblotting with antibodies that recognize the C or N-els. A. KCC2FL mice were generated with LoxP sites flanking exons 22–25. PCR products from
pon Cre expression, LoxP recombination resulted in deletion of the C-terminal portion of the
ith either control AAV9-CaMKII-eGFP (AAV-GFP) or AAV9-CaMKII-eGFP-Cre (AAV-Cre) and
othN- and C-terminal portions of the KCC2 proteinwere reduced in AAV-Cre treated cultures
d using ICC on virus treated cultures using the C-terminal antibody. F. Muscimol-activated
mps in gramicidin perforated patch recordings. The voltage ramp protocol is shown below
om AAV-GFP and AAV-Cre neurons. The estimated EGABA value is where the traces cross the
compared to controls. (***p b 0.001).
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the C-terminal antibody, which recognizes epitopes within 911–1096,
was dramatically reduced in neurons infected with AAV-Cre but not
those infected with AAV-GFP. Parallel reductions in immunoreactivity
were also seen with an antibody that recognizes the N-terminus of
KCC2 (Fig. 1B). Immunocytochemistry labeling confirmed the reduction
of KCC2 (Fig. 1C) Thus, deletion of residues 911-1096 leads to reduced
steady state accumulation of KCC2.
To assess if the Cre-induced deficits in KCC2 expression impact chlo-
ride homeostasis, we performed gramicidin perforated patch recordings
on cultured neurons 4 days after AAV infection. We measured EGABA byFig. 2.ReducingKCC2 in vivo in subset of principal neurons in thehippocampus. A. Adult KCC2FL
eGFP-Cre (AAV-Cre) or AAV9-CaMKII-eGFP (AAV-GFP). Arrows mark site of injection. (Scale ba
hippocampus of mice 21 days after virus injection (Scale bar = 100 μm). C. 100× image taken
CA1 principal cell layer and granule cells in the dentate gyrus with lack of KCC2 labeling (wh
dentate gyrus demonstrated a significant decrease of KCC2 in AAV-Cre injected mice (*p b 0.05calculating the reversal potential of leak-subtracted muscimol (1 μM; a
GABAAR agonist) currents during positive-directed voltage ramps. To
isolate the role of KCC2 in setting EGABA, we performed these recordings
in the presence of the NKCC1 inhibitor bumetanide (10 μM) and
blocked neuronal activity with TTX (500 nM) to prevent activity-
dependent Cl− accumulation. KCC2FL neurons infected with AAV-Cre
had a positive shift in EGABA compared with those infected with AAV-
GFP (Fig. 1D–F; AAV-GFP = −104 ± 3 mV, n = 11, AAV-Cre = −86
± 2mV, p b 0.001, n=15). Collectively these studies in culture suggest
that deletion of residues 911–1096within KCC2 decreases KCC2 expres-
sion levels, and elevated levels of intracellular Cl−.malemicewere injected bilaterally into thedorsal hippocampuswith either AAV9-CaMKII-
r = 200 μm). B. Immunohistochemical labeling of KCC2 and GFP expression in the dorsal
from AAV-Cre mice at 21 days post injection, demonstrating GFP positive neurons in the
ite arrows, Scale bar = 10 μm). D. Quantification of immunofluorescence in the CA1 and
, **p b 0.005, *** p b 0.0005).
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campus of KCC2FL Mice
To test the significance of our in vitro measurements, AAV-Cre or
AAV-GFP were bilaterally injected into the hippocampus of 6–8 wk.
old KCC2FL mice (Fig. 2A). The effects of viral infection on KCC2 expres-
sion levels was then examined 7–28 days after injection using immuno-
histochemistry coupled with confocal microscopy.
GFP expression was evident in the hippocampus of KCC2FL mice
injected with either virus with robust endogenous fluorescence being
seen in the CA1 and dentate gyrus (DG; Fig. 2A, B). 100× Z-stack images
taken at 21 days post showed loss KCC2 in GFP positive neurons, from
mice infected with AAV-Cre (Fig. 2C). In the AAV-Cre injected mice,
GFP positive neuronswith deficits in KCC2 expression were found adja-
cent to non-infected neuronswhich exhibited high levels of KCC2 stain-
ing. To provide quantitative information on expression levels, KCC2
immunoreactivity was measured in defined regions of interest (ROI)
within CA1 and dentate gyrus (DG) of mice 7, 14, 21 or 28 days post
virus. Steady state accumulation of KCC2 was observed significantly re-
duced in both CA1 andDG in AAV-Cre comparedwith AAV-GFP using an
antibody recognizing an epitope within the C-terminus (Measured as
percent of AAV-GFP controls, CA1: 7-day: 99.4 ± 11.9% p = 0.9597,
14-day: 95.8 ± 9.7% p = 0.6827, 21-day: 28.6 ± 3.6% p b 0.0001, 28-
day: 56.8 ± 0.7% p b 0.0001, AAV-Cre DG: 7-day: 99.3 ± 7.7% p =
0.933, 14-day: 53.4 ± 16.1% p = 0.044, 21-day: 40.6 ± 9.9% p =
0.0038, 28-day: 47.8 ± 5.9% p=0.0009). Thus, our viral strategy results
in focal and specific deficits in KCC2 expression levels within the
hippocampus.
3.3. Reducing KCC2 Expression in the Hippocampus Leads to Elevations in
Neuronal Cl- Levels and Deficits in GABAergic Inhibition
To assess the effects of reducing KCC2 expression on GABAAR signal-
ing, we prepared acute hippocampal slices from mice 14–17 days after
virus infection. Perforated patch clamp recordings were performed on
dentate gyrus granule cells (DGGCs) which exhibited GFP fluorescence.
A puffer pipette containing muscimol (10 μM) was placed in theFig. 3. Conditional deletion of KCC2 inmature dentate granule cells results in a shift in EGABA. Denta
either AAV-Cre or AAV-GFP. A. Infected neurons were identified by GFP fluorescence and targeted
Hil=Hilus, Scale bar=30 μm). B.Muscimol pulseswere applied at differentmembrane holding p
to those infectedwith AAV-GFP. C. Muscimol (10 μM, 500ms) pulses established the direction of G
in the driving force of GABAAmediated currents compared to AAV-GFP. D. Sliceswere treatedwith
measured periodically every 20s at holding potential of−70mV. Example traces from AAV-GFP
obtained before and after the VU0463271 was calculated. AAV-Cre granule cells displayed loss ofmolecular layer to elicit GABAAR mediated currents (Fig. 3A). The
NKCC1 inhibitor bumetanide was applied to inhibit the contribution of
NKCC1 and the voltage-gated sodium channel inhibitor TTX to block ac-
tivity dependent shifts in Cl−. Steady state GABAAR-mediated currents
were then measured at several holding potentials and this data used to
determine EGABA. DGGCs infected with AAV-Cre showed more positive
EGABA values compared to those infected with AAV-GFP (Fig. 3B; AAV-
GFP=−94± 3mV, AAV-Cre=−59±7mV, p=0.002, n=6). In I=
0recordings, 5 of 6 AAV-Cre infectedDGGCs exhibited depolarizingmem-
brane potential responses to muscimol, while only 1 of 6 AAV-GFP in-
fected DGGCs showed a depolarizing response. Subtracting VM from
EGABA values showed that AAV-Cre infection flipped the GABAAR driving
force (DFGABA) from negative to positive values (Fig. 3C; DFGABAAAV-
GFP=−12±4mV, DFGABAAAV-Cre=18±10mV, p=0.021, n= 6).
To further analyze Cl− extrusion, we assessed the effects of the KCC2
inhibitor VU0463271 (1 μM) on EGABA over a 15 min time course for
DGGCs held at −70 mV [11,33]. In DGGCs infected with AAV-GFP,
muscimol-activated currents became progressively smaller but were un-
affected in those infected with AAV-Cre (Fig. 3D). EGABA was then deter-
mined at 15min of treatment with VU0463271 infected neurons (AAV-
GFP =−69 ± 5 mV, AAV-Cre=−57 ± 4 mV n= 5–6, p= 0.1025).
ΔEGABA was found as the difference between pre and post VU0463271
EGABA values. This parameter exhibited a significant positive shift in
AAV-GFP compared to those infected with AAV-Cre (Fig. 3E; AAV-GFP
= 25± 6mV, AAV-Cre=2±4mV, p= 0.010, n= 5–6). Finally, there
was nodifference in restingmembrane potential between the two groups
(AAV-GFP=−83± 5mV; AAV-Cre=−82± 8mV, p=0.914, n=6).
Thus, reducing KCC2 expression levels in the dentate gyrus leads to in-
creased neuronal Cl− accumulation and the appearance of depolarizing
GABAAR currents, hallmarks of compromised GABAergic inhibition.
3.4. KCC2FL Mice Infected with AAV-Cre Develop Spontaneous Seizures
To assess the significance of reducing KCC2 activity on the develop-
ment of epilepsy, KCC2FLmicewere subject to continuous EEG/EMG and
video recording for up to 21 days after injection of AAVs. 2-channel EEG
recordings were processed using DClamp Software, and generalizedte granule cellswere patched in acute coronal slices prepared fromKCC2FLmice injectedwith
for gramicidin perforated patch recordings (ML=molecular layer, GCL=granule cell layer,
otentials to determine EGABA. AAV-Cre granule cells showed a positive shift in EGABA compared
ABAAR signalingwhile holding the cell in I=0. AAV-Cre granule cells showed a positive shift
the KCC2 inhibitor VU0463271 (1 μM, 15min) and the amplitude of muscimol currentswas
and AAV-Cre dentate granule cells. E. The difference between between EGABA measurements
EGABA sensitivity to VU0463271 (*p b 0.05, **p b 0.005).
Fig. 4. Reducing KCC2 in the adult hippocampus results in generalized seizure activity. A. Continuous EEG/EMG paired video recordings were performed from KCC2FL mice injected with
either AAV-Cre or AAV-GFP into the dorsal hippocampus. Example seizure from an AAV-Cre injected KCC2FL mouse along with wavelet spectrogram demonstrating frequency power
content of the signal. B. Zoomed traces of seizure event shown in A. C. All AAV-Cre infected mice demonstrated generalized seizures, while no seizures were observed in AAV-GFP mice
(n=8 each group). D. Seizure frequency in AAV-Cre group in days post virus injection. E. The mean seizure duration from AAV-Cre group was 54.4 ± 2.9 s (n=154 seizures).
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These generalized seizures were characterized by increased EEG
power and behavioral tonic-clonic seizures (Fig. 4A and Supplementary
Videos 1 and 2). All mice infected with AAV-Cre developed generalized
seizureswhile no seizureswere evident in those infectedwith AAV-GFP
(n = 8 mice per treatment). The mean onset of generalized seizures
was 16.3 ± 3.0 days following injection of AAV-Cre (Fig. 4C, n = 154
seizures). At 21-days post AAV-Cre injection, KCC2FL mice had a
mean 2 ± 1 generalized seizures per day (Fig. 4D). Seizure events
had a mean duration of 54.4 ± 2.9 s (Fig. 4E). Thus, focally reducing
KCC2 expression in the hippocampus is sufficient to induce spontane-
ous, generalized seizures.
3.5. KCC2FL Mice Infected With AAV-Cre Develop Gliosis and Neuronal Loss
In addition to spontaneous seizures, mTLE is characterized by pro-
found hippocampal changes which include increased gliosis and de-
creased neuronal number [3,34]. Therefore, we assessed if reducing
KCC2 activity in the hippocampus has any effects on these parameters.
We first stained brain sections from infected mice with antibodies
against glial fibrillary acidic protein (GFAP), the expression of which is
dramatically increased in reactive astrocytes [35]. Slices visualized
using confocal microscopy and low power images revealed a dramatic
increase in GFAP immunoreactivity in the hippocampus of mice injected
with AAV-Cre but not those with AAV-GFP (Fig. 5A). To provide quanti-
tative information we compared GFAP immunoreactivity in CA1 or DG
of mice 21 days after infection. Increased GFAP staining was evident in
the CA1 of mice infected with AAV-Cre relative to AAV-GFP (Fig. 5C;
AAV-GFP= 17,750± 7192 GFAP+ pixels/mm2, AAV-Cre=149,777±
40,908 GFAP+ pixels/mm2, n= 3 mice, p= 0.0336). Similar increase
in GFAP levels were seen in the DG; (Fig. 5D; AAV-GFP = 17,728 ±
6962 GFAP+ pixels/mm2, n = 3 mice, AAV-Cre = 115,547 ± 28,819
GFAP+ pixels/mm2, n=3 mice, p=0.030).To examine possible effects on neuronal number, sections were
stained with antibodies against NeuN, a neuronal specific protein. The
number of NeuN positive cells was then determined in GFP positive
ROIs within the CA1 and DG regions. 21 days after infection there
was a significant decrease in the number of NeuN positive cells in
CA1 of mice infected with AAV-Cre compared to AAV-GFP (Fig. 6;
AAV-GFP = 109 ± 4 cells/100 μm2, AAV-Cre: 78 ± 6 cells/100 μm2,
p=0.011, n=3mice). In contrast, the number of NeuN positive struc-
tures was comparable in the DG granule cell layer (Fig. 6C; AAV-GFP=
140 ± 4 cells/100 μm2, AAV-Cre=135± 11 cells/100 μm2, p=0.750,
n=3 mice).
To further explore the relationship between KCC2 activity and neu-
ronal viability we assessed the effects of reducing KCC2 expression in
neuronal culture. To do so, cultured neurons from KCC2FL mice were in-
fected with AAV-Cre or AAV-GFP at 18 Div. The number of GFP positive
cells was then compared 6 days later. The number of GFP expressing
neurons was significantly reduced in cultures infected with AAV-Cre
compared to AAV-GFP (Fig. 7 AAV-GFP: 17 ± 1 neurons/frame, AAV-
Cre: 8 ± 1 neurons/frame, p b 0.0001, n=12 frames taken from 3 cov-
erslips for each virus treatment). Thus, KCC2 expression per-se appears
to be a determinant of mature neuronal viability in this reduced
preparation.
Collectively these results suggest that in addition to precipitating
spontaneous seizures, decreasing KCC2 levels in the hippocampus
leads to gliosis throughout the hippocampus and neuronal loss in CA1.
Moreover, our studies in neuronal culture suggest that decreasing
KCC2 is sufficient to decrease neuronal viability.
4. Discussion
The mechanisms that underlie the development of mesial temporal
lobe epilepsy (mTLE) are poorly understood. It is generally accepted
that deficits in the efficacy of GABAergic inhibition are of significance
Fig. 5.Reducing KCC2 locally in hippocampus results in the development of reactive astrogliosis. A. KCC2FLmicewere injectedwith either AAV-Cre, or AAV-GFP. Coronal slices prepared 21
days post-viral injection were labeled for GFAP, a marker of reactive gliosis (Scale bar= 200 μm). B. Image of the dorsal hippocampus of KCC2FL mice infected with AAV-Cre, or AAV-GFP.
Region of interest (dashed lines)were drawn around complete CA1 orDG (Scale bar = 200 μm) and images quantified using binary threshold for GFAP. C. Expanded images from B (white
boxes) of CA1 pyramidal layer. Mice infectedwith AAV-Cre, mice showed an increase in GFAP-labeled area and reactive astroglia. D. Expanded images from B (white boxes) of DG granule
cell layer. Mice infected with AAV-Cre, showed an increase in GFAP-labeled area and reactive astroglia in GFP positive areas (*p b 0.05, Scale bar = 50 μm).
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perpolarization caused by Cl− influx, and accordingly deficits in KCC2
are seen in humans and animal models of epilepsy. Here we have ad-
dressed if focally reducing KCC2 in adult mouse hippocampus directly
contributes to the development of the underlying pathophysiology of
mTLE. Using stereotaxic injection, we locally infected the hippocampus
of KCC2FL mice with AAV virus expressing Cre under the control of the
CaMKIIα promoter, facilitating specific recombination and KCC2 deletion
in pyramidal neurons [32]. To validate our approach, we first infected
cultured hippocampal neurons from KCC2FL mice and showed through
immunoblotting that 18 DIV Cre-expressing neurons displayed gross de-
creases in the expression levels of KCC2 compared to Cre-negative con-
trols. In parallel, gramicidin perforated patch experiments demonstrated
that EGABA was positively shifted reflecting increased Cl− accumulation.
Our results suggest that deletion of the C-terminus of native expressed
KCC2 leads to its degradation, and parallel deficits in KCC2 activity.To assess if our studies in culture translated to similar events in the
brain, we introduced AAVs into the hippocampus of 6–8-week-old
KCC2FL mice using stereotaxic injection. We then examined viral infec-
tion using immunofluorescence up to several weeks after infection.
GFP expressionwas evidentwithin the hippocampus shortly after injec-
tion. The expression levels of KCC2 were then compared between GFP-
Cre and GFP-Cre-negative control injectedmice. Time dependent reduc-
tions in KCC2 expression were only evident in GFP-Cre expressingmice
and seen in both CA1 and the DG. In keeping with these reductions in
KCC2 expression, significant positive shifts in EGABA were recorded in
GFP-Cre but not GFP-Cre-negative DG cells 14–17 days post virus injec-
tion. Furthermore, these EGABA shifts resulted in a switch from hyperpo-
larizing to depolarizing GABAAR currents. The role that KCC2 activity
plays in regulating neuronal Cl- accumulation in the brain has recently
been questioned by a recent publication suggesting that neuronal Cl-
levels are determined by impermeant anions within the extracellular
Fig. 6. Reducing KCC2 locally in hippocampus results in neuronal loss in CA1. A. KCC2FL mice were injected with either AAV-Cre or AAV-GFP. Coronal slices prepared 21 days post-viral
injection were labeled for NeuN, a neuronal marker. Region of interests of 100 μm2 were drawn in area CA1 pyramidal layer or DG granule cell layer. White boxes are magnified in B
and C (Scale bar = 200 μm). B. NeuN positive cells were counted in GFP positive regions of CA1 pyramidal layer (Scale bar = 50 μm). Arrows in expanded images of NeuN labeling
indicate sites of neuronal loss. There was a reduction in NeuN positive cells within the CA1 pyramidal layer in AAV-Cre mice (*p b 0.05). C. NeuN positive cells were counted in GFP-
positive regions of DG granule cell layer. No significant difference in cell count was observed.
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critical in setting EGABA and the efficacy of fast GABAergic inhibition in
cultured hippocampal neurons and in acute brain slices.
Computational modeling has suggested that reducing the efficacy of
KCC2mediatedCl− transport in a subset of pyramidal neurons increases
the probability of seizure-like events [37]. To directly test this hypothe-
sis in vivo, we performed continuous paired EEG and video recordings
on KCC2FLmicewith induced focal deficits in KCC2 in the hippocampus.
All mice infectedwith GFP-Cre developed spontaneous, generalized sei-
zures that recurred sporadically over the entire duration of our record-
ings. We observed no seizures in mice infected with GFP-Cre-negative.
Thus, our results suggest that compromising KCC2 expression within
subset of pyramidal neurons in the hippocampus is sufficient to induce
epilepsy. Consistent with our results, deficits in KCC2 activity have been
widely reported in convulsant-induced animal models of epilepsy inrodents prior to the onset of generalized seizures [21,23], and in brain
tissue surgically removed from refractory mTLE patients [17–20]. Our
results support that deficits in KCC2 activity within pyramidal neurons
of mature neuronal networks is a likely contributing factor to the initia-
tion of epileptiform activity.
Central to the progression and pathophysiology of mTLE is the ob-
servation of hippocampal sclerosis (HS), which is reproduced in animal
models [34,38,39]. Thus, we assessed in parallel with the appearance of
spontaneous seizures if focal deletion of KCC2 in the hippocampus leads
to sclerosis. Significantly, the critical hallmarks of sclerosis—reduced
neuronal number and enhanced gliosis—were seen in the hippocampus
of KCC2FL mice expressing GFP-Cre but not GFP alone. It is interesting to
note that deletion of KCC2 appeared to selectively induce neuronal loss
in CA1 compared to the DG. Similar preferential losses of CA1 neurons
are seen in humans with mTLE [41], but the underlying mechanisms
Fig. 7. Reducing KCC2 decreases neuronal viability in vitro. A. Neuronal cultures from
KCC2FL mice were treated with either control AAV9-CaMKII-eGFP (GFP) or AAV9-
CaMKII-eGFP-Cre (Cre) at DIV 18 and GFP positive cells counted at DIV 24. B. There was
a cell-loss of GFP positive cells in AAV-Cre treated cultures (*p b 0.001).
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be explored. Consistent with our experiments in whole animals, Cre-
mediated deletion of KCC2 was sufficient to reduce neuronal viability
of cultured KCC2FL neurons. These findings support a former study
that showed that decreasing KCC2 levels in mature neuronal culture
using shRNA decreases neuronal viability [42]. Our results are the first
experiment in vivo to show that ablating KCC2 in subsets of neurons re-
sults in decreased neuronal viability.
In summary, our results suggest that locally compromising KCC2 ac-
tivity within the hippocampus is sufficient to reproduce the core phys-
iological and anatomical deficits associated with mesial temporal lobe
epilepsy with hippocampal sclerosis, including spontaneous, recurring
seizures, neuronal loss and gliosis. Thus, agents that potentiate KCC2 ac-
tivity may be useful in treating mTLE.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ebiom.2018.05.029.
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Research in Context
Mesial temporal lobe epilepsy (mTLE) is the most common form of
human epilepsy and arises largely due to deficits in the strength of
inhibitory neurotransmission, a process that is in part dependent
upon the neuron specific K+/Cl− co-transporter KCC2. To directly test
the role KCC2 plays in mTLE we have used genetic manipulation to re-
duce its activity in subsets of neurons in the mouse hippocampus.Reducing KCC2 activity compromised neuronal inhibition and was
sufficient to precipitate mTLE. Collectively these results suggest that
deficits in KCC2 activity directly contribute to the development of
mTLE. Thus, agents that elevate KCC2 activity may be useful treatments
for mTLE.
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